.
ResMed Inc. (ASX:RMD, NYSE:RMD) has announced an annual profit boost of 12 per cent, underpinned by growth from its US markets.
The manufacturer and distributor of medical equipment generated a net profit of $254.9 million, an increase of more than $25 million from the previous financial year.
Resmed says American revenue lifted by 13 per cent in the fourth quarter while revenue from the rest of the business grew by 3 per cent over the year.
In the first half of the 2012 financial year ResMed reported a net profit of $112.6 million.
- Forums
- ASX - By Stock
- RMD
- News: ResMed FY12 profit up 12%
News: ResMed FY12 profit up 12%
Add RMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$38.55 |
Change
0.440(1.15%) |
Mkt cap ! $22.38B |
Open | High | Low | Value | Volume |
$38.50 | $38.74 | $38.25 | $21.46M | 557.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 1771 | $38.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$38.55 | 114 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13767 | 14.400 |
2 | 17668 | 14.390 |
3 | 20967 | 14.380 |
2 | 14124 | 14.370 |
4 | 21382 | 14.360 |
Price($) | Vol. | No. |
---|---|---|
14.430 | 22863 | 3 |
14.440 | 27216 | 4 |
14.450 | 46627 | 8 |
14.460 | 34563 | 7 |
14.470 | 22668 | 7 |
Last trade - 14.40pm 28/11/2024 (20 minute delay) ? |
RMD (ASX) Chart |